Somaiya Mayur Ian 4
4 · NewAmsterdam Pharma Co N.V. · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Somaiya Mayur Ian
Chief Financial Officer
Transactions
- Sale
Ordinary Shares
2025-01-28−3,405→ 38,000 total - Exercise/Conversion
Option (Right to Buy)
2025-01-28−14,900→ 762,814 totalExercise: $9.26Exp: 2033-11-01→ Ordinary Shares (14,900 underlying) - Exercise/Conversion
Ordinary Shares
2025-01-27$9.26/sh+46,983$435,063→ 84,983 total - Sale
Ordinary Shares
2025-01-27−33,679→ 51,304 total - Sale
Ordinary Shares
2025-01-28−11,495→ 41,405 total - Exercise/Conversion
Option (Right to Buy)
2025-01-27−46,983→ 777,714 totalExercise: $9.26Exp: 2033-11-01→ Ordinary Shares (46,983 underlying) - Sale
Ordinary Shares
2025-01-27−13,304→ 38,000 total - Exercise/Conversion
Ordinary Shares
2025-01-28$9.26/sh+14,900$137,974→ 52,900 total
Footnotes (6)
- [F1]This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares were sold in multiple transactions at prices ranging from $22.38 per share to $23.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
- [F3]These shares were sold in multiple transactions at prices ranging from $23.38 per share to $23.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
- [F4]These shares were sold in multiple transactions at prices ranging from $20.93 per share to $21.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
- [F5]These shares were sold in multiple transactions at prices ranging from $21.93 per share to $22.41 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction.
- [F6]The option was granted on November 1, 2023. 25% of the shares underlying the option vested on the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.